Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave

Author:

Lu Guanzhu1,Zhang Yi2,Zhang Haocheng2,Ai Jingwen23,He Liu4,Yuan Xiaoling1,Bao Suxia1,Chen Xiaohua5,Wang Hongyu2,Cai Jianpeng2,Wang Sen23,Zhang Wenhong23,Xu Jie1

Affiliation:

1. Department of Infectious Disease, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

2. Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China

3. Huashen Institute of Microbes and Infections, Shanghai, People’s Republic of China

4. Medical section, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

5. Department of Infectious Disease, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Funder

National Natural Science Foundation of China

Shanghai Municipal Science and Technology Major Project

Shanghai Science and Technology Committee

Shanghai Municipal Health Commission

Infectious Disease Department and Hospital-Acquired Infection Control Department

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Reference30 articles.

1. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [assessed 2022 Jun 12]. Available from: https://www.arcgis.com/apps/opsdashboard/index.html#bda7594740fd40299423467b48e9ecf6[EB/OL]

2. Outbreak.info. [assessed 2022 May 28]. Available from: https://outbreak.info/situation-reports/omicron

3. Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages

4. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

5. Antibody evasion properties of SARS-CoV-2 Omicron sublineages

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3